Why Different Symptoms Become Prominent

Valsa Madhava, MD

12 minutes ago

4 min read

Week 8 of the Symptom Patterns Series (Series 4)

Why the symptoms that stand out can change over time — one symptom at a time, not the whole pattern at once.

The Picture Doesn't Stay the Same

During withdrawal, the symptom picture may not stay fixed. The symptoms that feel most prominent can change over time. One symptom may ease while another becomes more noticeable.

This is worth describing carefully, because it is easy to misread. What changes is which individual symptoms stand out—not a whole named pattern moving as a block.

One Symptom at a Time

The key point is that this happens at the level of individual symptoms. Different symptoms can follow different courses: one settles while another comes forward, on its own timing.

It does not mean that a whole named pattern rises and falls as a single unit. The patterns from earlier in this series are ways of describing what is prominent at a given time—not machines that switch on and off together. So when the picture shifts, the honest way to describe it is "these particular symptoms changed," not "the threat pattern turned off and the motor pattern turned on."

Different Symptoms, Different Courses

There is no single timeline that describes withdrawal. Studies that followed symptoms over time have found that trajectories are heterogeneous—they differ from symptom to symptom and from person to person, and no one curve captures them all.

Some studies suggest that certain symptoms may become more prominent later in a taper or around cessation, but this is not a rule and should not be expected in everyone. Other symptoms may peak earlier, or show no clear phase-linked change.

What the Evidence Can — and Cannot — Say

What is known about symptom change over time comes from published longitudinal and taper-follow-up studies, including prospective or controlled studies of benzodiazepine tapering and discontinuation, together with clinical observation. That evidence is descriptive and heterogeneous.

It is also worth being clear about a limit. The exploratory analysis used elsewhere in this series is a single snapshot in time—it compares people at one point, and it cannot describe how symptoms change over the course of a taper. So nothing in the earlier articles' analysis should be read as evidence about trajectories.

And none of this predicts an individual course. Knowing that symptom prominence can shift does not tell any particular person what their symptoms will do, when, or in what order.

What This Means for You

A change in which symptoms are prominent may happen and, by itself, does not necessarily carry a hidden meaning. A new symptom coming forward does not necessarily mean things are getting worse, and the easing of one does not guarantee a smooth road — symptoms can follow varied courses.

As always, a new, severe, or unexpected symptom still deserves appropriate medical evaluation; a shift in the picture is not a reason to assume everything is "just withdrawal."

These patterns are not diagnoses, do not establish a mechanism, and do not predict what will happen, and no medication should be changed on the basis of a symptom picture alone.

Figure 8. How prominent symptoms can change over time

This figure shows individual symptom labels changing in prominence across a few time periods—not colored blocks labeled as whole patterns. Individual symptoms may change in prominence over time. This does not mean that a whole named pattern rises and falls as one unit, and it does not predict any individual course.

Transition to the Final Article

Across this series we have described what the patterns are, what they are not, how they overlap, and how the prominent symptoms can change. The final article steps back to ask what recognizing these patterns can add—and what they cannot tell us.

About the Evidence

This article draws on published studies that followed benzodiazepine-withdrawal symptoms over time and on clinical observation, together with the Five-Axis Stress Biology Framework™ educational framework. Symptom courses are heterogeneous—they differ by symptom and by person, and no single trajectory describes withdrawal generally. Descriptions of change apply to individual symptoms, not to whole patterns moving as a unit, and they do not predict any individual's course. The single-time-point analysis used elsewhere in this series does not describe change over time. These descriptions are not diagnoses, do not establish a mechanism, do not replace individual medical evaluation, and no medication should be changed on the basis of them alone.

Selected Scientific References

Ashton, H. (1991). Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment, 8(1–2), 19–28. https://doi.org/10.1016/0740-5472(91)90023-4
O'Sullivan, G. H., Swinson, R., Kuch, K., Marks, I. M., Basoglu, M., & Noshirvani, H. (1996). Alprazolam withdrawal symptoms in agoraphobia with panic disorder: Observations from a controlled Anglo-Canadian study. Journal of Psychopharmacology, 10(2), 102–108. https://doi.org/10.1177/026988119601000204
Shade, K. N., et al. (2025). Long-term neurological consequences following benzodiazepine exposure: A scoping review. PLOS ONE, 20(8), e0330277. https://doi.org/10.1371/journal.pone.0330277
Vikander, B., Koechling, U. M., Borg, S., Tönne, U., & Hiltunen, A. J. (2010). Benzodiazepine tapering: A prospective study. Nordic Journal of Psychiatry, 64(4), 273–282. https://doi.org/10.3109/08039481003624173

These studies support the observation that symptom prominence can change over time and that symptom courses are heterogeneous; they do not describe whole-pattern co-movement and do not predict an individual patient's course. The organization analysis used elsewhere in Series 4 is cross-sectional (a single time point) and is not a source for trajectories; it is the author's own exploratory analysis, in preparation for publication and not yet posted or externally replicated.

For educational purposes only. Not a substitute for individual medical evaluation.